Enfermedad articular degenerativa; Osteoartritis hipertrófica; Osteoartrosis; EAD; Osteoartritis (artritis)
Nota: puede ser asintomática.
Un examen fÃsico puede indicar rango limitado de movimiento, crepitación de las articulaciones con el movimiento, asà como sensibilidad e inflamación articular.
Una radiografÃa de las articulaciones afectadas muestra pérdida del espacio articular y, en casos avanzados, desgaste de los extremos del hueso y espolones óseos.
Harris ED, Budd RC, Genovese MC, Firestein GS, Sargent JS, Sledge CB, Kelley's Textbook of Rheumatology , 7th ed. St. Louis, MO; W.B. Saunders; 2005.
US Food and Drug Administration. FDA Announces Series of Changes to the Class of Marketed Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) . Rockville, MD: National Press Office; April 7, 2005. Press Release P05-16.
US Food and Drug Administration. FDA Issues Public Health Advisory Recommending Limited Use of Cox-2 Inhibitors . Rockville, MD: National Press Office; December 23, 2004. Talk Paper T04-61.
|
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch). |